Fred Telling

CIK 1382225 · last filed 2026-01-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$588

Companies

3

Total Filings

78

Lifetime Open-Market Net

$146.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OGEN Director 948 $0.62 $588 $679.7K 33 2026-01-22
CTI BIOPHARMA CORP (CTIC) Delisted Director 78,874 $9.09 $717.0K $0 8 2018-09-20
CTI BIOPHARMA CORP (TRGT) Delisted Director 417,490 -$533.2K 29 2014-03-07

Recent Filings · Page 3 of 8

78 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-06-24 OGEN Grant (A) $0 EDGAR
2019-03-27 OGEN Buy (P) +100,000 $0 EDGAR
2018-10-01 OGEN Grant (A) $0 EDGAR
2018-09-20 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
2018-07-17 OGEN Buy (P) +100,000 $0 EDGAR
2018-06-26 OGEN Grant (A) +4,000 $0 EDGAR
2018-05-17 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
2017-06-26 OGEN Grant (A) $0 EDGAR
2017-05-02 CTI BIOPHARMA CORP (CTIC) Delisted Exer (M) +34,736 $0 EDGAR
2017-02-27 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
Showing 2130 of 78
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.